Jingman Ni

1.9k total citations
82 papers, 1.6k citations indexed

About

Jingman Ni is a scholar working on Molecular Biology, Microbiology and Organic Chemistry. According to data from OpenAlex, Jingman Ni has authored 82 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 54 papers in Molecular Biology, 40 papers in Microbiology and 17 papers in Organic Chemistry. Recurrent topics in Jingman Ni's work include Antimicrobial Peptides and Activities (40 papers), Chemical Synthesis and Analysis (23 papers) and Biochemical and Structural Characterization (18 papers). Jingman Ni is often cited by papers focused on Antimicrobial Peptides and Activities (40 papers), Chemical Synthesis and Analysis (23 papers) and Biochemical and Structural Characterization (18 papers). Jingman Ni collaborates with scholars based in China, Macao and United Kingdom. Jingman Ni's co-authors include Sanhu Gou, Chao Zhong, Ningyi Zhu, Yuewen Zhu, Jia Yao, Tianqi Liu, Beibei Li, Rui Wang, Junqiu Xie and Fangyan Zhang and has published in prestigious journals such as Analytical Biochemistry, Scientific Reports and Journal of Medicinal Chemistry.

In The Last Decade

Jingman Ni

75 papers receiving 1.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jingman Ni China 24 994 770 316 181 134 82 1.6k
Stella Cascioferro Italy 31 1.5k 1.5× 374 0.5× 1.5k 4.6× 118 0.7× 126 0.9× 86 3.0k
Barbara Parrino Italy 34 1.3k 1.3× 273 0.4× 1.6k 5.1× 96 0.5× 81 0.6× 76 2.9k
Frank M. Unger Austria 29 1.3k 1.3× 133 0.2× 763 2.4× 416 2.3× 147 1.1× 93 2.2k
Sanhu Gou China 19 665 0.7× 654 0.8× 152 0.5× 130 0.7× 93 0.7× 50 1.0k
Santanu Kar Mahapatra India 25 456 0.5× 60 0.1× 185 0.6× 189 1.0× 132 1.0× 77 1.5k
Qosay Al‐Balas Jordan 19 662 0.7× 340 0.4× 163 0.5× 69 0.4× 39 0.3× 68 1.0k
Samuel K. Kutty Australia 14 621 0.6× 131 0.2× 271 0.9× 74 0.4× 19 0.1× 19 1.2k
Zulfiqar Ahmad United States 25 1.1k 1.1× 152 0.2× 110 0.3× 136 0.8× 35 0.3× 69 1.6k
Anna Jaromin Poland 22 580 0.6× 82 0.1× 294 0.9× 149 0.8× 45 0.3× 58 1.5k

Countries citing papers authored by Jingman Ni

Since Specialization
Citations

This map shows the geographic impact of Jingman Ni's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jingman Ni with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jingman Ni more than expected).

Fields of papers citing papers by Jingman Ni

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jingman Ni. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jingman Ni. The network helps show where Jingman Ni may publish in the future.

Co-authorship network of co-authors of Jingman Ni

This figure shows the co-authorship network connecting the top 25 collaborators of Jingman Ni. A scholar is included among the top collaborators of Jingman Ni based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jingman Ni. Jingman Ni is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ouyang, Xu, Tingting Yang, Beibei Li, et al.. (2025). Single or double lipid-modified ultra-short antimicrobial peptides for treating infections caused by resistant bacteria. European Journal of Medicinal Chemistry. 287. 117321–117321. 4 indexed citations
2.
Li, Jingyue, et al.. (2025). Design and Development of an Organocatalyst for Light Accelerated Amide and Peptide Synthesis. ACS Central Science. 11(7). 1240–1249. 1 indexed citations
3.
Chang, Linlin, Feng Wu, Yuxia Wang, et al.. (2025). A new short pH-responsive anticancer peptide derived by intramolecular charge shielding strategy. European Journal of Medicinal Chemistry. 291. 117662–117662.
4.
Wei, Jiayun, et al.. (2024). Organoid as a promising tool for primary liver cancer research: a comprehensive review. Cell & Bioscience. 14(1). 107–107. 3 indexed citations
5.
Yao, Jia, Yuxia Wang, Xu Ouyang, et al.. (2024). Rational design of a new short anticancer peptide with good potential for cancer treatment. European Journal of Medicinal Chemistry. 273. 116519–116519. 3 indexed citations
6.
Zhong, Chao, Jing Zou, Wenbo Mao, et al.. (2024). Structure modification of anoplin for fighting resistant bacteria. European Journal of Medicinal Chemistry. 268. 116276–116276. 7 indexed citations
7.
Chang, Linlin, Xu Ouyang, Hui Liu, et al.. (2023). One New Acid-Activated Hybrid Anticancer Peptide by Coupling with a Desirable pH-Sensitive Anionic Partner Peptide. ACS Omega. 8(8). 7536–7545. 11 indexed citations
8.
Zhang, Fangyan, Chao Zhong, Jia Yao, et al.. (2022). Antimicrobial peptides–antibiotics combination: An effective strategy targeting drug‐resistant Gram‐negative bacteria. Peptide Science. 114(4). 8 indexed citations
9.
Zhong, Chao, Fangyan Zhang, Ningyi Zhu, et al.. (2020). Ultra-short lipopeptides against gram-positive bacteria while alleviating antimicrobial resistance. European Journal of Medicinal Chemistry. 212. 113138–113138. 51 indexed citations
10.
Liu, Tianqi, Ningyi Zhu, Chao Zhong, et al.. (2020). Effect of N-methylated and fatty acid conjugation on analogs of antimicrobial peptide Anoplin. European Journal of Pharmaceutical Sciences. 152. 105453–105453. 46 indexed citations
11.
Zhong, Chao, Sanhu Gou, Tianqi Liu, et al.. (2019). Study on the effects of different dimerization positions on biological activity of partial d-Amino acid substitution analogues of Anoplin. Microbial Pathogenesis. 139. 103871–103871. 24 indexed citations
12.
Li, Dong, Yun Zhang, Xia Wang, et al.. (2017). In vivo and in vitro anti-inflammatory effects of ethanol fraction from Periploca forrestii Schltr.. Chinese Journal of Integrative Medicine. 23(7). 528–534. 12 indexed citations
13.
Wang, Xiaoping, et al.. (2017). New monocyte locomotion inhibitory factor analogs protect against cerebral ischemia-reperfusion injury in rats. Bosnian Journal of Basic Medical Sciences. 17(3). 221–227. 7 indexed citations
14.
Gou, Sanhu, Haifeng Huang, Xinyue Chen, et al.. (2016). Lipid-lowering, hepatoprotective, and atheroprotective effects of the mixture Hong-Qu and gypenosides in hyperlipidemia with NAFLD rats. Journal of the Chinese Medical Association. 79(3). 111–121. 50 indexed citations
15.
Liu, Hui, et al.. (2014). The improved blood–brain barrier permeability of endomorphin-1 using the cell-penetrating peptide synB3 with three different linkages. International Journal of Pharmaceutics. 476(1-2). 1–8. 32 indexed citations
16.
Ni, Jingman. (2012). Separation and Purification Process of Total Flavonoids from Glycyrrhiza uralensis. Zhongguo shiyan fangjixue zazhi. 1 indexed citations
17.
Zhang, Xiaoyun, et al.. (2010). ジヒドロアルテミシニン負荷ナノ構造脂質担体(DHA‐NLC):ラットに対する静脈内投与後の薬動学と組織分布の評価. Pharmazie. 65(9). 670–678. 3 indexed citations
18.
Xu, Ying, Yingkai Zhang, Dong Li, et al.. (2010). Anti-metabolic syndrome effect of Licorice flavonoid dispersible tablets in a high fat diet-induced obesity/ type 2 diabetes mouse model. 亚洲传统医药. 5(3). 89–101. 1 indexed citations
19.
Wang, Changlin, Chao Guo, Yiqing Wang, et al.. (2010). Synthesis and antinociceptive effects of endomorphin-1 analogs with C-terminal linked by oligoarginine. Peptides. 32(2). 293–299. 12 indexed citations
20.
Ni, Jingman. (2006). α-Glucosidase Inhibitors from Glycyrrhiza uralensis Fisch.. Journal of Chinese Pharmaceutical Sciences. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026